Brought to you by 
MediciNova completes $113.4mm IPO
20 Jul 2005
Executive Summary
MediciNova (focused primarily on developing compounds for urological and gynecological conditions) has netted $113.4mm (Y11.9bn) with its initial public offering of 31.6mm shares (including the overallotment) priced at $3.88 each. The company, which exceeded its hopes of bringing in $100mm, sold shares to Japanese and other ex-US investors and is now listed on the Hercules Market of the Osaka Securities Exchange
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MediciNova completes $113.4mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice